c-GMP Activators

The c-GMP activators are a unique family of chemical compounds that enhance the activity of c-GMP through precise biochemical pathways that c-GMP is directly involved in. Sodium Nitroprusside, Nitroglycerin, Molsidomine, and Isosorbide Dinitrate are compounds that generate nitric oxide in the body. Nitric oxide is a potent activator of soluble guanylate cyclase (sGC), the enzyme that directly catalyzes the synthesis of c-GMP from GTP. This catalytic process is fundamental as it leads to the generation and increased activity of c-GMP. Sildenafil, Tadalafil, Vardenafil, Zaprinast, and Avanafil belong to a group of compounds known as phosphodiesterase type 5 (PDE5) inhibitors. PDE5 is the enzyme that primarily degrades c-GMP in cells. By inhibiting PDE5, these compounds prevent the degradation of c-GMP, leading to an increase in c-GMP levels and thus enhanced activity of c-GMP. This mechanism is integral as it ensures the persistence of c-GMP within the cells, leading to prolonged and enhanced signaling that is mediated by c-GMP.

Riociguat is a stimulator of sGC and functions by enhancing the sensitivity of sGC to endogenous nitric oxide. This is achieved by stabilizing the binding of nitric oxide to sGC, which enhances the production of c-GMP, thereby increasing its activity. Dipyridamole inhibits phosphodiesterases, preventing the degradation of c-GMP and leading to an increase in its levels, thus enhancing its activity. This mechanism allows for the prolonged presence and enhanced activity of c-GMP in the cellular system. Alprostadil, while it can increase c-GMP degradation via the activation of prostaglandin E receptors and subsequent stimulation of adenylate cyclase, can also directly stimulate sGC. This direct stimulation enhances the production of c-GMP, leading to an increase in its activity. This dual action of Alprostadil presents a complex interaction with the c-GMP pathway, where its overall effect could depend on the balance between these two processes.